|
1
|
Grivennikov S, Greten F and Karin M:
Immunity, inflammation, and cancer. Cell. 140:883–899. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Baldewijns MM, van Vlodrop IJ, Schouten
LJ, Soetekouw PM, de Bruïne AP and van Engeland M: Genetics and
epigenetics of renal cell cancer. Biochim Biophys Acta.
1785:133–155. 2008.PubMed/NCBI
|
|
3
|
Fisher R, Gore M and Larkin J: Current and
future systemic treatments for renal cell carcinoma. Semin Cancer
Biol. 23:38–45. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Fernández-Pello S, Hofmann F, Tahbaz R,
Marconi L, Lam TB, Albiges L, Bensalah K, Canfield SE, Dabestani S,
Giles RH, et al: A systematic review and meta-analysis comparing
the effectiveness and adverse effects of different systemic
treatments for non-clear cell renal cell carcinoma. Eur Urol.
71:426–436. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Barretina J, Caponigro G, Stransky N,
Venkatesan K, Margolin AA, Kim S, Wilson CJ, Lehár J, Kryukov GV,
Sonkin D, et al: The cancer cell line encyclopedia enables
predictive modelling of anticancer drug sensitivity. Nature.
483:603–607. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Vizin T and Kos J: Gamma-enolase: A
well-known tumour marker, with a less-known role in cancer. Radiol
Oncol. 49:217–226. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Levin VA, Panchabhai SC, Shen L, Kornblau
SM, Qiu Y and Baggerly KA: Different changes in protein and
phosphoprotein levels result from serum starvation of high-grade
glioma and adenocarcinoma cell lines. J Proteome Res. 9:179–191.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yan T, Skaftnesmo KO, Leiss L, Sleire L,
Wang J, Li X and Enger PØ: Neuronal markers are expressed in human
gliomas and NSE knockdown sensitizes glioblastoma cells to
radiotherapy and temozolomide. BMC Cancer. 11:5242011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hafner A, Obermajer N and Kos J:
γ-1-Syntrophin mediates trafficking of γ-enolase towards the plasma
membrane and enhances its neurotrophic activity. Neurosignals.
18:246–258. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hafner A, Obermajer N and Kos J: γ-Enolase
C-terminal peptide promotes cell survival and neurite outgrowth by
activation of the PI3K/Akt and MAPK/ERK signalling pathways.
Biochem J. 443:439–450. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sturgeon C: Practice guidelines for tumor
marker use in the clinic. Clin Chem. 48:1151–1159. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sun C, Liu M, Zhang W, Wang S, Qian G,
Wang M and Zhang G: Overexpression of enolase 2 is associated with
worsened prognosis and increased glycikolysis in papillary renal
cell carcinoma. J Cell Physiol. 236:3821–3831. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Szklarczyk D, Gable A, Lyon D, Junge A,
Wyder S, Huerta-Cepas J, Simonovic M, Doncheva NT, Morris JH, Bork
P, et al: STRING v11: Protein-protein association networks with
increased coverage, supporting functional discovery in genome-wide
experimental datasets. Nucleic Acids Res. 47(D1): D607–D613. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chin CH, Chen SH, Wu HH, Ho CW, Ko MT and
Lin CY: cytoHubba: Identifying hub objects and sub-networks from
complex interactome. BMC Syst Biol. 8 (Suppl 4):S112014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Maere S, Heymans K and Kuiper M: BiNGO: A
cytoscape plugin to assess overrepresentation of gene ontology
categories in biological networks. Bioinformatics. 21:3448–3449.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang C, Peng G, Huang H, Liu F, Kong DP,
Dong KQ, Dai LH, Zhou Z, Wang KJ, Yang J, et al: Blocking the
feedback loop between neuroendocrine differentiation and
macrophages improves the therapeutic effects of enzalutamide
(MDV3100) on prostate cancer. Clin Cancer Res. 24:708–723. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Subramanian A, Tamayo P, Mootha VK,
Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub
TR, Lander ES and Mesirov JP: Gene set enrichment analysis: A
knowledge-based approach for interpreting genome-wide expression
profiles. Proc Natl Acad Sci USA. 102:15545–15550. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bindea G, Mlecnik B, Tosolini M,
Kirilovsky A, Waldner M, Obenauf AC, Angell H, Fredriksen T,
Lafontaine L, Berger A, et al: Spatiotemporal dynamics of
intratumoral immune cells reveal the immune landscape in human
cancer. Immunity. 39:782–795. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hänzelmann S, Castelo R and Guinney J:
GSVA: Gene set variation analysis for microarray and RNA-seq data.
BMC Bioinformatics. 14:72013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Jiang P, Gu S, Pan D, Fu J, Sahu A, Hu X,
Li Z, Traugh N, Bu X, Li B, et al: Signatures of T cell dysfunction
and exclusion predict cancer immunotherapy response. Nat Med.
24:1550–1558. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Singh M, Yelle N, Venugopal C and Singh
SK: EMT: Mechanisms and therapeutic implications. Pharmacol Ther.
182:80–94. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Jiang Y and Zhan H: Communication between
EMT and PD-L1 signaling: New insights into tumor immune evasion.
Cancer Lett. 468:72–81. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yoshihara K, Shahmoradgoli M, Martínez E,
Vegesna R, Kim H, Torres-Garcia W, Treviño V, Shen H, Laird PW,
Levine DA, et al: Inferring tumour purity and stromal and immune
cell admixture from expression data. Nat Commun. 4:26122013.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Eissmann M, Dijkstra C, Jarnicki A, Phesse
T, Brunnberg J, Poh AR, Etemadi N, Tsantikos E, Thiem S, Huntington
ND, et al: IL-33-mediated mast cell activation promotes gastric
cancer through macrophage mobilization. Nat Commun. 10:27352019.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Mukaida N, Sasaki SI and Baba T: CCL4
signaling in the tumor microenvironment. Adv Exp Med Biol.
1231:23–32. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lan J, Sun L, Xu F, Liu L, Hu F, Song D,
Hou Z, Wu W, Luo X, Wang J, et al: M2 macrophage-derived exosomes
promote cell migration and invasion in colon cancer. Cancer Res.
79:146–158. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yang J, Antin P, Berx G, Blanpain C,
Brabletz T, Bronner M, Campbell K, Cano A, Casanova J, Christofori
G, et al: Author correction: Guidelines and definitions for
research on epithelial-mesenchymal transition. Nat Rev Mol Cell
Biol. 22:8342021. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Mittal V: Epithelial mesenchymal
transition in tumor metastasis. Annu Rev Pathol. 13:395–412. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Bai J, Zhang X, Shi D, Xiang Z, Wang S,
Yang C, Liu Q, Huang S, Fang Y, Zhang W, et al: Exosomal miR-128-3p
promotes epithelial-to-mesenchymal transition in colorectal cancer
cells by targeting FOXO4 via TGF-β/SMAD and JAK/STAT3 signaling.
Front Cell Dev Biol. 9:5687382021. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Morel A, Lièvre M, Thomas C, Hinkal G,
Ansieau S and Puisieux A: Generation of breast cancer stem cells
through epithelial-mesenchymal transition. PLoS One. 3:e28882008.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Shibue T and Weinberg RA: EMT, CSCs, and
drug resistance: The mechanistic link and clinical implications.
Nat Rev Clin Oncol. 14:611–629. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Thiery JP, Acloque H, Huang RY and Nieto
MA: Epithelial-mesenchymal transitions in development and disease.
Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kudo-Saito C, Shirako H, Takeuchi T and
Kawakami Y: Cancer metastasis is accelerated through
immunosuppression during Snail-induced EMT of cancer cells. Cancer
Cell. 15:195–206. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Díaz-Montero CM, Rini BI and Finke JH: The
immunology of renal cell carcinoma. Nat Rev Nephrol. 16:721–735.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Tran Janco JM, Lamichhane P, Karyampudi L
and Knutson KL: Tumor-infiltrating dendritic cells in cancer
pathogenesis. J Immunol. 194:2985–2991. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Stanton SR and Disis ML: Clinical
significance of tumor-infiltrating lymphocytes in breast cancer. J
Immunother Cancer. 4:592016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Pandey G: Tumor-associated macrophages in
solid tumor: Friend or foe. Ann Transl Med. 8:10272020. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Fridlender ZG and Albelda SM:
Tumor-associated neutrophils: Friend or foe? Carcinogenesis.
33:949–955. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Zeng D, Li M, Zhou R, Zhang J, Sun H, Shi
M, Bin J, Liao Y, Rao J and Liao W: Tumor microenvironment
characterization in gastric cancer identifies prognostic and
immunotherapeutically relevant gene signatures. Cancer Immunol Res.
7:737–750. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Wang ZH, Peng WB, Zhang P, Yang XP and
Zhou Q: Lactate in the tumour microenvironment: From immune
modulation to therapy. EBioMedicine. 73:1036272021. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Xia H, Wang W, Crespo J, Kryczek I, Li W,
Wei S, Bian Z, Maj T, He M, Liu RJ, et al: Suppression of FIP200
and autophagy by tumor-derived lactate promotes naïve T cell
apoptosis and affects tumor immunity. Sci Immunol. 2:eaan46312017.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Husain Z, Seth P and Sukhatme VP:
Tumor-derived lactate and myeloid-derived suppressor cells: Linking
metabolism to cancer immunology. Oncoimmunology. 2:e263832013.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Erra Díaz F, Ochoa V, Merlotti A, Dantas
E, Mazzitelli I, Gonzalez Polo V, Sabatté J, Amigorena S, Segura E
and Geffner J: Extracellular acidosis and mTOR inhibition drive the
differentiation of human monocyte-derived dendritic cells. Cell
Rep. 31:1076132020. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Nasi A, Fekete T, Krishnamurthy A, Snowden
S, Rajnavölgyi E, Catrina AI, Wheelock CE, Vivar N and Rethi B:
Dendritic cell reprogramming by endogenously produced lactic acid.
J Immunol. 191:3090–3099. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Certo M, Tsai CH, Pucino V, Ho PC and
Mauro C: Lactate modulation of immune responses in inflammatory
versus tumour microenvironments. Nat Rev Immunol. 21:151–161. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Marin-Acevedo JA, Dholaria B, Soyano AE,
Knutson KL, Chumsri S and Lou Y: Next generation of immune
checkpoint therapy in cancer: New developments and challenges. J
Hematol. 11:392018.PubMed/NCBI
|
|
48
|
Gentles AJ, Newman AM, Liu CL, Bratman SV,
Feng W, Kim D, Nair VS, Xu Y, Khuong A, Hoang CD, et al: The
prognostic landscape of genes and infiltrating immune cells across
human cancers. Nat Med. 21:938–945. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Gajewski TF, Schreiber H and Fu YX: Innate
and adaptive immune cells in the tumor microenvironment. Nat
Immunol. 14:1014–1022. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Joyce JA and Fearon DT: T cell exclusion,
immune privilege, and the tumor microenvironment. Science.
348:74–80. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Spranger S and Gajewski TF:
Tumor-intrinsic oncogene pathways mediating immune avoidance.
Oncoimmunology. 5:e10868622016. View Article : Google Scholar : PubMed/NCBI
|
